BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19706757)

  • 1. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.
    Stern MC; Lin J; Figueroa JD; Kelsey KT; Kiltie AE; Yuan JM; Matullo G; Fletcher T; Benhamou S; Taylor JA; Placidi D; Zhang ZF; Steineck G; Rothman N; Kogevinas M; Silverman D; Malats N; Chanock S; Wu X; Karagas MR; Andrew AS; Nelson HH; Bishop DT; Sak SC; Choudhury A; Barrett JH; Elliot F; Corral R; Joshi AD; Gago-Dominguez M; Cortessis VK; Xiang YB; Gao YT; Vineis P; Sacerdote C; Guarrera S; Polidoro S; Allione A; Gurzau E; Koppova K; Kumar R; Rudnai P; Porru S; Carta A; Campagna M; Arici C; Park SS; Garcia-Closas M;
    Cancer Res; 2009 Sep; 69(17):6857-64. PubMed ID: 19706757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
    Fontana L; Bosviel R; Delort L; Guy L; Chalabi N; Kwiatkowski F; Satih S; Rabiau N; Boiteux JP; Chamoux A; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(3B):1853-6. PubMed ID: 18630471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
    Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
    Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.
    Wu Y; Yang Y
    Tumour Biol; 2014 Jun; 35(6):5245-57. PubMed ID: 24504678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai.
    Corral R; Lewinger JP; Van Den Berg D; Joshi AD; Yuan JM; Gago-Dominguez M; Cortessis VK; Pike MC; Conti DV; Thomas DC; Edlund CK; Gao YT; Xiang YB; Zhang W; Su YC; Stern MC
    Int J Cancer; 2014 Jul; 135(2):335-47. PubMed ID: 24382701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
    Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
    Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
    Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers.
    Wen H; Feng CC; Fang ZJ; Xia GW; Jiang HW; Xu G; Huang XD; Ding Q
    Actas Urol Esp; 2013 May; 37(5):259-65. PubMed ID: 23246108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
    Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk.
    Andrew AS; Mason RA; Kelsey KT; Schned AR; Marsit CJ; Nelson HH; Karagas MR
    Toxicol Lett; 2009 May; 187(1):10-4. PubMed ID: 19429237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
    Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
    Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.
    Rouissi K; Bahria IB; Bougatef K; Marrakchi R; Stambouli N; Hamdi K; Cherif M; Ben Slama MR; Sfaxi M; Othman FB; Chebil M; Elgaaied AB; Ouerhani S
    BMC Cancer; 2011 Mar; 11():101. PubMed ID: 21426550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population.
    Samara M; Papathanassiou M; Mitrakas L; Koukoulis G; Vlachostergios PJ; Tzortzis V
    Curr Oncol; 2021 May; 28(3):1879-1885. PubMed ID: 34068981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India.
    Gangawar R; Ahirwar D; Mandhani A; Mittal RD
    Med Oncol; 2010 Jun; 27(2):159-66. PubMed ID: 19242824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
    García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility.
    Huang M; Dinney CP; Lin X; Lin J; Grossman HB; Wu X
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):84-91. PubMed ID: 17220334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma.
    Smedby KE; Lindgren CM; Hjalgrim H; Humphreys K; Schöllkopf C; Chang ET; Roos G; Ryder LP; Falk KI; Palmgren J; Kere J; Melbye M; Glimelius B; Adami HO
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):258-65. PubMed ID: 16492913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.